Features | Partner Sites | Information | LinkXpress
Sign In
KOREA E & EX
Ampronix
GLOBETECH PUBLISHING LLC

New Limits to Magnesium for Preventing Preterm Labor

By HospiMedica International staff writers
Posted on 14 Jun 2013
The US Food and Drug Administration (FDA; Silver Spring, MD, USA) advise clinicians not to give pregnant women magnesium sulfate (MgSO4) for more than 5–7 days, as it may harm developing fetal bones.

The FDA decision was based on a review of 18 case reports in the agency's Adverse Event Reporting System; in these cases, women were given the drugs for an average of 9.6 weeks, for an average total dose of 3,700 mg over treatment period. Abnormalities resulting in their offspring included fractures of the long bones and ribs, which may have been caused by fetal hypermagnesemia and the resulting hypocalcemia.

The FDA also reviewed the epidemiologic evidence. In one study, significantly more bone anomalies were seen in newborns that had been exposed to MgSO4 for more than one week, compared with only three days of exposure. Another study found differences in levels of osteocalcin, magnesium, calcium, and phosphorus at birth in babies exposed for longer than a week. The abnormalities seen in neonates in both studies after MgSO4 exposure of more than 5–7 days included radiographic findings of radiolucent transverse metaphyseal bands of long bones such as the humerus.

The FDA will change the teratogenicity category of MgSO4 from Pregnancy category D, rather than A, and a warning that longer off-label administration for tocolysis can lead to low calcium levels and osteopenia or fractures in the baby will be added to the drug's labeling. The labeling will also be amended to stress that injectable MgSO4 is not indicated for prevention of preterm labor, that its efficacy and safety for this use have not been established, and that it should only be administered by trained healthcare professionals in well-equipped hospitals.

“Pregnant women should discuss with their healthcare professional the possibility of going into labor before term and the risks and benefits of any treatments that may be used,” stated the FDA advisory. “However, the long-term significance of these findings is not known because of inadequate follow-up, and it is unknown whether a shorter duration of treatment is associated with calcium and bone abnormalities in the neonate.”

MgSO4 is an inorganic salt containing magnesium, sulfur, and oxygen, and is the first-line anti-arrhythmic agent for torsades de pointes in cardiac arrest. It is also used as a bronchodilator in severe exacerbations of asthma, and to treat eclampsia in pregnant women. It delays labor by inhibiting uterine muscle contraction in the case of premature labor. A recent systematic review suggests that antenatal intravenous MgSO4 can also reduce the risk of cerebral palsy and gross motor dysfunction in preterm infants by on average 30%.

Related Links:
US Food and Drug Administration




Inditherm
Harloff
JD Honigberg International

Channels

Surgical Techniques

view channel
Image: The Intact Tissue Excision System (Photo courtesy of Intact Medical).

Minimally Invasive System Removes Intact Breast Lesions

Physicians can now excise breast lesions in their entirety, thus preserving their architectural integrity for diagnostic assessment. The Intact Tissue Excision System surrounds and excises an entire... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Hospital News

view channel
Image: The new Parkland Memorial Hospital (Photo courtesy of Parkland Memorial Hospital).

New Parkland Memorial Hospital Nears Completion

At nearly twice the size of the current hospital, the new Parkland Memorial Hospital (Dallas, TX, USA) will be one of the first “digital hospitals” in the United States. The new hospital, built at... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.